Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53358

言語	英語
著者	Kato Takayuki Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Honda Yasushi Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Kurita Yusuke Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Iwasaki Akito Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Sato Takamitsu Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Kessoku Takaomi Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Uchiyama Shiori Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Ogawa Yuji Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Ohkubo Hidenori Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Higurashi Takuma Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Yamanaka Takeharu Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokoahama, Kanagawa, Japan 臼田春樹和田孝一郎 Nakajima Atsushi Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
掲載誌名	PLOS ONE
巻	12
号	4
ISSN	1932-6203
発行日	2017-04-14
DOI	10.1371/journal.pone.0175626
PubMed ID	28410406
出版者	PUBLIC LIBRARY SCIENCE
資料タイプ	学術雑誌論文
部局	医学部
備考	This research was funded by a grant from Mylan EPD G.K. (Mylan EPD), which is the distributor of lubiprostone in Japan. There are no grant numbers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.